MFDS Approves Domestic Clinical Trials for COVID-19 Vaccine Developed by US Innovio Inc.
[Asia Economy Reporter Choi Dae-yeol] The domestic clinical trial of the novel coronavirus disease (COVID-19) vaccine candidate (INO-4800) developed by the U.S. pharmaceutical company Inovio will commence.
According to the pharmaceutical industry on the 3rd, the International Vaccine Institute (IVI) received approval from the Ministry of Food and Drug Safety for phase 1 and phase 2 clinical trials of Inovio's COVID-19 vaccine candidate 'INO-4800' in South Korea.
This is the first time a COVID-19 vaccine clinical trial has been approved in South Korea. IVI received approval just 12 days after applying for the clinical trial with the Ministry of Food and Drug Safety.
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Physical Assault and Other Violence"… Final Letter of National Institute of Fisheries Science Researcher
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The clinical trial is scheduled to be conducted this month at Seoul National University Hospital, targeting healthy adults.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
